前沿论文｜CELL INTELLIGENCE

Targeting GD2 with naxitamab overcomes GD3 synthase-driven immune suppression in triple-negative breast cancer.

PubMed 2025/11/05 发表NPJ Breast CancerQ1 · IF 8.4（JCR 2025）

CAR-T cell therapy and reconstructive oncologic surgery in peripheral solid tumors-A narrative review.

PubMed 2025/07/16 发表Cell Rep MedQ1 · IF 14（JCR 2025）

Expanding the Therapeutic Reach of Chimeric Antigen Receptor T-Cells and Bispecific T-Cell Engagers Across Solid Tumors.

PubMed 2025/03/26 发表JCO Precis OncolQ2 · IF 4.7（JCR 2025）

前沿论文 3